4BIO Capital

← Back to your selection

Activity in this selectiongodrej-industries-group-ff383cd3

Rounds participated in: 2
Confirmed lead rounds: 2
New companies: 2
Funding in participating rounds: $78.4M

By stage

Seed2

By primary sector

Biotech2

By country

Italy1

United States1

Rounds

2 in this selection

Sep 29

Aptadir Therapeutics

RNA therapeutics designed to restore expression of silenced genes

€40MSeed

Lead

Sep 8

Cloverleaf Bio

Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical.

$33MSeed

Lead